JPRN-UMIN000018986
Completed
未知
Examination of usefulness and safety of heparinoid agent based external medicine (over counter drug) for facial dryness symptom. - Usefulness of heparinoid agent based external medicine for facial dryness symptom.
Osaka city university graduate school of medicine, department of dermatology0 sites50 target enrollmentSeptember 30, 2015
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Osaka city university graduate school of medicine, department of dermatology
- Enrollment
- 50
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •The person 1\. Who takes in an oral pharmaceutical product or a supplement which may affect the skin condition habitually. 2\. Who had the anamnestic history of surgical operation on the testing area. 3\. Who is infected with hemorrhagic disease. 4\. Who has skin rash of atopic dermatitis on face. 5\. Who uses regularly an external medicine. 6\. Who had the anamnesis of heparinoid allergy. 7\. Who has allergy or sensitivity to drug and cosmetics. 8\. Who can not agree that using same cosmetics all over the study time. 9\. Who has skin disease on the testing area. 10\. Who has the factor on the testing area which may affect the result. 11\. Who has critical illness of glucose metabolism, lipid metabolism, liver function, renal function, cardiovascular system, respiratory tract, endocrine system, immune system and nervous system, or had the anamnestic history of psychiatric disorder. 12\. Who can not understand about examination contents. 13\. Who is pregnant or lactating. 14\. Who is impossible to come to the testing institution on an examination day. 15\. Who participates in other examinations. 16\. Who is recognized to be inappropriate as a subject by attending physician.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
sefulness of topical heparinoid in the treatment of asteatosis in hemodialyzed patientsasteatosis in hemodialyzed patientJPRN-UMIN000029360ippon medical school hospital76
Completed
Phase 2
Heparin administration in coronary angiographyAtherosclerotic heart disease.Atherosclerotic heart diseaseIRCT201202199080N1Hamadan university of medical sciences500
Completed
Not Applicable
Effect OF Heparin solution for prevention of pain and swelling at the site of peripheral intravenous catheter.Health Condition 1: O- Medical and SurgicalCTRI/2017/10/010089PARUL INSTITUTE OF MEDICAL SCIENCE AND RESEARCH100
Not yet recruiting
Phase 2
The Evaluation of effectiveness of heparin nebulizer in reduction of respiratory distress in patients with COVID-19COVID-19.COVID-19, virus identifiedU07.1IRCT20210513051275N1Islamic Azad University60
Not yet recruiting
Phase 1
A trial to assess the safety of nebulised heparin for acute lung injuryAcute lung injuryRespiratory - Other injuries and accidentsACTRN12606000388516St Vincents Health Melboune20